Michael Kassiou

35PUBLICATIONS

86CO-AUTHORS

Cheminformatics and quantitative structure-activity relationshipsOptical properties of materialsPredictive and prognostic markersGene and molecular therapyImmunogenetics (incl. genetic immunology)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (35)

Sort by Publication Date:

|Jul 08, 2026

Molecular Hybridization of Clinically Relevant P2X7 Antagonists.

|Jun 17, 2026

Psychedelics and Entactogens.

|Dec 15, 2025

Histone methyltransferase PRDM9 promotes survival of drug-tolerant persister cells in glioblastoma.

George L Joun, Emma G Kempe, Brianna Chen

|Mar 10, 2025

PK 11195 derivatives: exploring the influence of amide and heterocyclic substitution on A147T TSPO discrimination.

Renee Sokias, Andrea Zhao, Eryn L Werry

|Feb 05, 2025

Development and evaluation of [<sup>11</sup>C]DPA-813 and [<sup>18</sup>F]DPA-814: novel TSPO PET tracers insensitive to human single nucleotide polymorphism rs6971.

Wissam Beaino, Esther Jm Kooijman, Eryn L Werry

|May 23, 2024

An Investigation on Linker Modifications of Cyanoguanidine-Based P2X7 Receptor Antagonists.

Taylor R Garrett, Jayson Gilchrist, Andre D J McKenzie

Pageof 6

Frequent Collaborators

David Hibbs

Andrew P Montgomery

Jonathan J Danon

Mark Connor

André D J Mckenzie

Lenka Munoz

Samuel D Banister

Lars M Ittner

Marina Santiago

Mingming Xu

Frequent Collaborators

David Hibbs

Andrew P Montgomery

Jonathan J Danon

Mark Connor